# Exosome-like Nanovesicles from Hordeum vulgare L. Fermented with Lactiplantibacillus plantarum BMSE-HMP251 Ameliorate LPS-Induced Inflammation in HT-29 and RAW 264.7 Cells

**Authors:** Duna Yu, Jeong-Eun Lee, Jin Hong Kim, Jung Soo Kim, Si Jun Park, Ki-Young Kim, Hana Jung, Moochang Kook

PMC · DOI: 10.3390/molecules31040679 · Molecules · 2026-02-15

## TL;DR

Fermenting barley with a breast milk-derived probiotic boosts the anti-inflammatory power of plant-based nanovesicles.

## Contribution

Fermentation with Lactiplantibacillus plantarum BMSE-HMP251 enhances anti-inflammatory activity of barley-derived exosome-like nanovesicles.

## Key findings

- Fermented EVs showed higher DPPH radical scavenging activity.
- Fermented EVs suppressed nitric oxide and proinflammatory cytokine mRNA expression more effectively.
- Fermentation improved physicochemical properties and safety of plant-derived EVs.

## Abstract

Human breast milk harbors commensal lactic acid bacteria with probiotic potential, and microbial fermentation may enhance the bioactivity of plant-derived exosome-like nanovesicles (EVs); this study evaluated whether L. plantarum BMSE-HMP251 isolated from breast milk could safely ferment Hordeum vulgare L. and improve the anti-inflammatory activity of derived EVs. BMSE-HMP251 was identified by 16S rRNA sequencing and characterized by biochemical, safety, and genomic analyses. EVs derived from Hordeum vulgare L. extract and BMSE-HMP251-fermented broth were evaluated for physicochemical properties, antioxidant activity, cytotoxicity, and anti-inflammatory activity in LPS-stimulated HT-29 and RAW 264.7 cells. EVs derived from Hordeum vulgare L. fermentation exhibited a distinct size distribution and significantly enhanced bioactivity, including higher DPPH radical scavenging activity and greater suppression of nitric oxide production and proinflammatory cytokine (TNF-α and IL-1β) mRNA expression, compared with EVs from unfermented extracts. These effects were observed following fermentation with the human breast milk-derived strain L. plantarum BMSE-HMP251, which showed species-consistent phenotypic and genomic characteristics and no safety concerns. Overall, fermentation markedly enhances the anti-inflammatory potential of plant-derived EVs, supporting fermentation as a safe and effective strategy to improve their functional value.

## Linked entities

- **Proteins:** TNF (tumor necrosis factor), IL1B (interleukin 1 beta)
- **Chemicals:** nitric oxide (PubChem CID 145068)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, GUSB (glucuronidase beta) [NCBI Gene 2990] {aka BG, MPS7}, OGA (O-GlcNAcase) [NCBI Gene 10724] {aka MEA5, MGEA5, NCOAT}, SI (sucrase-isomaltase) [NCBI Gene 6476], IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}
- **Diseases:** infections (MESH:D007239), colitis (MESH:D003092), cytotoxic (MESH:D064420), immune dysregulation (OMIM:614878), chronic (MESH:D002908), Dysbiosis (MESH:D064806), cancer (MESH:D009369), D-lactic acidosis (MESH:D000140), short bowel syndrome (MESH:D012778), injury to (MESH:D014947), Inflammation (MESH:D007249), ischemia (MESH:D007511), Hemolysis (MESH:D006461)
- **Chemicals:** Dexamethasone (MESH:D003907), phosphoric acid (MESH:C030242), amino acid (MESH:D000596), potassium persulfate (MESH:C009007), Carbohydrate (MESH:D002241), BMSE- (-), dextran (MESH:D003911), sulfanilamide (MESH:D000077145), penicillin (MESH:D010406), polysorbate 80 (MESH:D011136), lutonarin (MESH:C000600695), flavonoids (MESH:D005419), CO2 (MESH:D002245), LPS (MESH:D008070), 2,2'-azino-bis-(3-ethylbenzothiazoline)-6-sulfonic acid (MESH:C002502), lipid (MESH:D008055), lactic acid (MESH:D019344), Polyethylene glycol (MESH:D011092), 1,1-diphenyl-2-picrylhydrazyl (MESH:C004931), chlorophyll (MESH:D002734), streptomycin (MESH:D013307), lipoteichoic acid (MESH:C009900), saponarin (MESH:C457771), pyruvate (MESH:D019289), ascorbic acid (MESH:D001205), N-(1-naphthyl)ethylenediamine dihydrochloride (MESH:C008588), ethanol (MESH:D000431), NO (MESH:D009569), cholesterol (MESH:D002784), water (MESH:D014867), phospholipids (MESH:D010743), Griess reagent (MESH:C095000), TRIzol (MESH:C411644), Oil Red O (MESH:C011049)
- **Species:** Limosilactobacillus fermentum CECT 5716 (strain) [taxon 712938], Leptospira sp. AB (species) [taxon 103236], Homo sapiens (human, species) [taxon 9606], Hordeum vulgare (barley, species) [taxon 4513], Limosilactobacillus reuteri (species) [taxon 1598], Lactiplantibacillus plantarum (species) [taxon 1590], Mus musculus (house mouse, species) [taxon 10090], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Bacillus cereus (species) [taxon 1396], Glycine max (soybean, species) [taxon 3847]
- **Cell lines:** Caco-2 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0025), KACC 11451T — Homo sapiens (Human), Amyotrophic lateral sclerosis, Transformed cell line (CVCL_BG68), YJBR3 — Mus musculus (Mouse), Hybridoma (CVCL_C6V6), HT-29 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0320), RAW 264.7 — Mus musculus (Mouse), Mouse leukemia, Cancer cell line (CVCL_0493)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12943092/full.md

## Figures

14 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12943092/full.md

## References

79 references — full list in the complete paper: https://tomesphere.com/paper/PMC12943092/full.md

---
Source: https://tomesphere.com/paper/PMC12943092